Haven't used Daru Darman Aria Sepahan yet?
Ask Trustburn

Questions about Daru Darman Aria Sepahan

Based on 5 reviews, listing data and website checks · updated 4 days ago

What is Daru Darman Aria Sepahan?

Daru Darman Aria Sepahan (DDAS) is a healthcare import/export company founded in 2015 in Esfahan, Iran, by pharmacists. The business focuses on providing pharmaceutical products with an emphasis on identifying and developing pain management treatments. They support healthcare professionals, patients, and caregivers through educational programs and partnerships while aiming to build long-term business relationships with manufacturers.

What is the core mission and priority of DDAS?

The company's stated mission is to improve patients' lives globally by ensuring no patient is deprived of high quality and affordable medicines. DDAS combines science with compassionate care to provide medical products of value to patients and the healthcare system. Their top priority continues to be identifying and developing pain treatments while educating the healthcare community about responsible pain management.

Where is the company based and what drives its business philosophy?

DDAS is located in Esfahan, Iran, and operates as a private company founded by pharmacists who recognized the importance of pain management. The business philosophy expresses a goal to contribute to the health of people around the world through the provision of highly effective and trustworthy pharmaceuticals. They seek to enhance enterprise value sustainably through worldwide business activities and gaining the trust of all stakeholders.

How does DDAS support its partners and customers beyond just supplying medications?

The company dedicates vast resources to educational programs, partnerships, and resources for healthcare professionals, patients, and caregivers. DDAS believes that its biggest asset is the zeal to achieve the highest quality customer service by delivering world-class products and valuable relationships with all manufacturers. They are committed to developing a mutually beneficial long-term relationship between DDAS and other companies to deliver more reliable pharmaceutical products.

What are the key goals for patients and partners?

DDAS aims to ensure that no patient shall be deprived of high quality and affordable medicines as part of their global mission. The company is dedicated to improving the therapies that healthcare professionals rely on to treat and manage disease. They prefer long-lasting business relationships to short-term success when building their network of partners.

What guiding principle does the company use to measure its success?

The website states that success begins with a simple question: Have We Made a Difference? This question reflects their focus on the impact they can make within the communities where they work and live. DDAS measures their commitment to changing tomorrow not only by bringing innovative new medicines to patients but also by the importance they place on community impact.

What is the background and founding story of DDAS?

DDAS is a young healthcare import/export company with innovative and talented professionals dedicated to improving the health of people around the world. The company was founded in 2015 in Esfahan, Iran, and is committed to advancing the medical care of patients with quality products. They focus on identifying and developing pain treatments while educating the healthcare community about responsible pain management.

What values and commitments guide DDAS's operations?

The company's website emphasizes that the greatest measure of a champion is their impact on another's life. DDAS seeks to enhance its enterprise value in a sustainable manner through its worldwide business activities and to gain the trust of all stakeholders. They must proactively take measures to ensure legal compliance and corporate accountability and to conserve the environment based on their recognition.

What specific focus areas does DDAS prioritize in its pharmaceutical work?

DDAS's top priority is to continue to identify and develop pain treatments and to educate the healthcare community about responsible pain management. The company is committed to improving the therapies that healthcare professionals rely on to treat and manage disease. Beyond the medications they make, they dedicate vast resources to educational programs, partnerships, and resources for healthcare professionals, patients, and caregivers.

What is the official website of Daru Darman Aria Sepahan?

The official website of Daru Darman Aria Sepahan is ddaspharma.ir.

How is Daru Darman Aria Sepahan rated on Trustburn?

On Trustburn, Daru Darman Aria Sepahan has a rating of 4.2 out of 5 based on 5 reviews.

Based on reviews, listing data and the company's website. Verify anything important with the company directly.

Jordan Blake
Reviews 1

Having direct email contacts for key personnel like the Marketing Manager and Technical Manager makes reaching out straightforward, although navigating the broader team structure could be slightly more intuitive.

Lena Winters
Reviews 1

It is reassuring to see that DDAS has a concrete list of marketed products, including specific dosages of Gliclazide and combination therapies. This transparency regarding their current offerings, alongside their pipeline for other therapeutic areas, suggests a company that is actively managing its inventory and planning for future needs. The variety in their portfolio indicates a broad capability to address different medical requirements effectively.

Marcus Vane
Reviews 1

Daru Darman Aria Sepahan presents itself as a dedicated healthcare import and export company established in 2015 by pharmacists in Esfahan, Iran. The available information highlights a strong emphasis on pain management and a mission to ensure that patients are not deprived of high-quality, affordable medicines. Their team includes various specialists such as a Managing Director, a Qualified Person, and technical managers who contribute to their operational structure. The company’s portfolio currently includes marketed products like Gliclazide ER and Amlodipine/Bisoprolol, with additional items in the pipeline for allergy and fungal conditions. They aim to strengthen their foothold in the Iranian marketplace while expanding into therapeutic areas like sleep, cardiology, dermatology, immunology, infectious disease, and urology. The narrative suggests a commitment to long-term business relationships and educational programs for healthcare professionals. While the specific details on their manufacturing capabilities are not fully detailed in the provided text, their stated goal of combining science with compassionate care indicates a professional approach to delivering reliable pharmaceutical products. The presence of a diverse team and a clear mission statement suggests an organization that values both innovation and customer service in the medical sector.

Elias Thorne
Reviews 1

Their focus on affordable medicines is promising, but the specific costs for the pipeline items are not yet listed, so I am wondering how the final pricing will compare to existing market options.

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="ddaspharma-ir" data-lang="en"></div>
More widgets

About Daru Darman Aria Sepahan

Daru Darman Aria Sepahan (DDAS) is a healthcare import/export company founded in 2015 in Esfahan, Iran, by pharmacists. The company focuses on providing pharmaceutical products, with an emphasis on identifying and developing pain management treatments. DDAS works to support healthcare professionals, patients, and caregivers through educational programs and partnerships, in addition to supplying medications. The company aims to build long-term business relationships with manufacturers and other partners to deliver reliable pharmaceutical products. Its stated mission is to improve patients' lives globally.